Pentacyclic Compound
AssigneeDaiichi Pharmaceutical Co., Ltd.
InventorsHirofumi Terasawa, Tsunehiko Soga, Takashi Ishiyama
Life of this patent
Estimating the term…
Loading patent…
AssigneeDaiichi Pharmaceutical Co., Ltd.
InventorsHirofumi Terasawa, Tsunehiko Soga, Takashi Ishiyama
Estimating the term…
The present invention relates to a novel taxol derivative having an antitumor activity which is represented by formula (1). [In the formula (I), R1: a phenyl group, R2: an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group or an alkoxyl group, R3: a hydrogen atom, a hydroxyl group, a halogen atom, an alkoxyl group, a group —O—R311 an acyloxy group or a group —O—CO—R31, (in which R31: an alkylamino group, an alkenyl group, an alkynyl group, a cycloalkyl group, an aryl group or a heterocyclic group), R4 and R5: a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group or a heterocyclic group, Z1: a hydrogen atom, a hydroxyl group, a halogen atom or an alkyl group, Z2: a hydrogen atom, a hydroxyl group, a halogen atom or an alkyl group, Z3: an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, an aryl group or a heterocyclic group].
A compound represented by the following formula (Ia) or a salt thereof:
Dependencies are inferred from the claim text.